Small-molecule inhibitors of NADPH oxidase 4

Journal of Medicinal Chemistry

Volumn 53, Issue 18, 2010, Pages 6758-6762

  Borbély, Gábor ^a   Szabadkai, István ^a   Horváth, Zoltán ^a   Markó, Péter ^a   Varga, Zoltán ^a   Breza, Nóra ^a   Baska, Ferenc ^a   Vántus, Tibor ^a   Huszár, Mónika ^a   Geiszt, Miklós ^a   Hunyady, László ^a   Buday, László ^a,b   Örfi, László ^a   Kéri, György ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ABRUQUINONE C; AMINOSALICYLIC ACID DERIVATIVE; APOCYNIN; BENZO[4,5]THIENO[3,2 D]PYRIMIDINE DERIVATIVE; GLIOTOXIN; GOMISIN; HONOKIOL; HYDROGEN PEROXIDE; INDOLE DERIVATIVE; MAGNOLOL; NEOPTERIN; NORATHYRIOL; OXALYLAMIDE DERIVATIVE; OXIDOREDUCTASE INHIBITOR; PERHEXILINE; PHENANTHRIDINONE DERIVATIVE; PRODIGIOSIN; PYRIMIDINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4 INHIBITOR; S 17834; UNCLASSIFIED DRUG; VAS 2870; FLAVONOID; NOX4 PROTEIN, HUMAN; OXALIC ACID DERIVATIVE; PHENANTHRENE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CELL STRAIN HEK293; ENZYME INHIBITOR INTERACTION; HUMAN; HUMAN CELL; IC 50; OXIDATIVE STRESS; STRUCTURE ACTIVITY RELATION; ANTAGONISTS AND INHIBITORS; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; SYNTHESIS;

AMINOSALICYLIC ACIDS; CELL LINE; FLAVONOIDS; HUMANS; HYDROGEN PEROXIDE; INDOLES; MODELS, MOLECULAR; NADPH OXIDASE; OXALIC ACIDS; PHENANTHRENES; PYRIMIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; OXALATES;

EID: 77956764327     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm1004368     Document Type: Article

References (26)

1. Cave, A. C.; Brewer, A. C.; Narayanapanicker, A.; Ray, R.; Grieve, D. J.; Walker, S.; Shah, A. M. NADPH oxidases in cardiovascular health and disease Antioxid. Redox Signaling 2006, 8 (5-6) 691-728
2. Bedard, K; Krause, K.-H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol Rev. 2007, 87, 245-313
3. Van Buul, J. D.; Fernandez-Borja, M.; Anthony, E. C.; Hordijk, P. L. Expression and localization of NOX2 and NOX4 in primary human endothelial cells Antioxid. Redox Signaling 2005, 7, 308-317
4. Guzik, T. J.; Sadowski, J.; Guzik, B.; Jopek, A.; Kapelak, B.; Przybylowski, P.; Wierzbicki, K.; Korbut, R.; Harrison, D. G.; Channon, K. M. Coronary artery superoxide production and Nox isoform expression in human coronary artery disease Arterioscler., Thromb., Vasc. Biol. 2006, 26, 333-339
5. Taddei, S.; Virdis, A.; Ghiadoni, L.; Magagna, A.; Salvetti, A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension Circulation 1998, 97, 2222-2229
6. Annuk, M.; Zilmer, M.; Lind, L.; Linde, T.; Fellstrom, B. Oxidative stress and endothelial function in chronic renal failure J. Am. Soc. Nephrol. 2001, 12, 2747-2752
7. Taniyama, Y.; Griendling, K. K. Reactive oxygen species in the vasculature Hypertension 2003, 42, 1075-1081
8. Jaquet, V.; Scapozza, L.; Clark, R.; Krause, K. H.; Lambeth, J. D. Small molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets Antioxid. Redox Signaling 2009, 11, 2535-2552
9. ODonnell, B. V.; Tew, D. G.; Jones, O. T.; England, P. J. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase Biochem. J. 1993, 290, 41-49
10. Cayatte, A. J.; Rupin, A.; Oliver-Krasinski, J.; Maitland, K.; Sansilvestri-Morel, P.; Boussard, M. F.; Wierzbicki, M.; Verbeuren, T. J.; Cohen, R. A. S17834, a new inhibitor of cell adhesion and atherosclerosis that targets nadph oxidase Arterioscler., Thromb., Vasc. Biol. 2001, 21 (10) 1577-1584
11. Seno, K.; Nishi, K.; Matsuo, Y.; Fujishita, T. Pyrazolo[1,5-A]pyrimidine Derivative and NAD(P)H Oxidase Inhibitor Containing the Same. US 2006/0089362, 2006. Shinogi & Co., Ltd., Osaka, Japan, 2006
12. Yamamoto, T.; Yamada, K. Specific NAD(P)H Oxidase Inhibitor. WO 2004/089412, 2004. Mitsubishi Pharma Corp., Osaka-shi, Japan, 2006.
13. Page, P.; Orchard, M.; Fioraso-Cartier, L.; Mottironi, B. Pyrazolo Pyridine Derivatives as NAD(P)H Oxidase Inhibitors. WO 2008/113856 A1, 2008; Genkyotex (CH).
14. Freyhaus, H.; Huntgeburth, M.; Wingler, K.; Schnitker, J.; Baumer, A. T.; Vantler, M.; Bekhite, M. M.; Wartenberg, M.; Seuer, H.; Rosenkranz, S. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation Cardiovasc. Res. 2006, 71, 331-341
15. Stielow, C.; Catar, R. A.; Muller, G.; Wingler, K.; Scheurer, P.; Schmidt, H. H.; Morawietz, H. Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells Biochem. Biophys. Res. Commun. 2006, 344 (1) 200-205
16. Bokoch, G. M.; Prossnitz, V. Isoprenoid metabolism is required for stimulation of the respiratory burst oxidase of HL-60 cells J. Clin. Invest. 1992, 89, 402-408
17. Groundwater, P. W.; Solomons, K. R.; Drewe, J. A.; Munawar, M. A. Protein tyrosine kinase inhibitors Prog. Med. Chem. 1996, 33, 233-329
18. Kuo, M. L.; Yang, N. C. Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes Biochem. Biophys. Res. Commun. 1995, 212 (3) 767-775
19. Chaumontet, C.; Bex, V.; Gaillard-Sanchez, I.; Seillan-Heberden, C.; Suschetet, M.; Martel, P. Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells Carcinogenesis 1994, 15 (10) 2325-2330
20. Dow, R. L.; Chou, T. T.; Bechle, B. M.; Goddard, C.; Larson, E. R. Identification of tricyclic analogs related to ellagic acid as potent/selective tyrosine protein kinase inhibitors J. Med. Chem. 1994, 37 (14) 2224-2231
21. Chen, H.; Boiziau, J.; Parker, F.; Maroun, R.; Tocque, B.; Roques, B. P.; Garbay-Jaureguiberry, C. Synthesis and structure-activity studies of a series of [(hydroxybenzyl)amino] salicylates as inhibitors of EGF receptor-associated tyrosine kinase activity J. Med. Chem. 1993, 36, 4094-4098
22. Sun, L.; Tran, N.; Tang, F.; App, H.; Hirth, P.; McMahon, G.; Tang, C. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases J. Med. Chem. 1998, 41 (14) 2588-2603
23. GB 1,206,401, 1966. Application date: Feb 23, 1961.
24. Örfi, L.; Wáczek, F.; Kövesdi, I.; Mészá ros, G.; Idei, M.; Horváth, A.; Hollósy, F.; Mák, M.; Szegedi, Z.; Szende, B.; Kéri, G. New antitumor leads from a peptidomimetic library Lett. Pept. Sci. 1999, 6 (5) 325-333
25. Showalter, H. D.; Bridges, A. J.; Zhou, H.; Sercel, A. D.; McMichael, A.; Fry, D. W. Tyrosine kinase inhibitors. 16. 6,5,6-Tricyclic benzothieno[3,2-d ]pyrimidines and pyrimido[5,4-b ]-and-[4,5-b ]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase J. Med. Chem. 1999, 42 (26) 5464-5474
26. Schrödinger Suite 2009; Schrödinger, LLC: Portland, OR, 2009.